ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 298

$507K Total Retail Price of All Prescriptions

Rank: 30 out of 298

360 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,219 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 485 396 1 3
AMLODIPINE BESYLATE 337 302 2 6
SIMVASTATIN 335 290 3 2
WARFARIN SODIUM 324 293 4 7
CARVEDILOL 300 263 5 23
LEVOTHYROXINE SODIUM 291 268 6 1
ATORVASTATIN CALCIUM 260 238 7 14
LISINOPRIL 252 241 8 4
HYDROCODONE-ACETAMINOPHEN 229 152 S3 9 8
BENAZEPRIL HCL 195 179 10 52
METFORMIN HCL 192 187 11 10
HYDROCHLOROTHIAZIDE 173 169 12 13
FUROSEMIDE 167 147 13 5
ATENOLOL 164 154 14 16
CRESTOR 164 135 14 26
CIPROFLOXACIN HCL 136 127 16 56
POLYETHYLENE GLYCOL 3350 135 135 17 29
ALENDRONATE SODIUM 133 129 18 21
PREDNISONE 131 117 19 33
DONEPEZIL HCL 127 127 20 22
CITALOPRAM HBR 122 110 21 17
GABAPENTIN 121 115 22 20
LOSARTAN POTASSIUM 120 96 23 18
METOPROLOL SUCCINATE 106 91 24 12
POTASSIUM CHLORIDE 103 101 25 11
TRAMADOL HCL 102 93 26 15
METOPROLOL TARTRATE 93 87 27 9
NITROGLYCERIN PATCH 89 80 28 106
DIGOXIN 88 81 29 27
MUPIROCIN 88 81 29 180
ALBUTEROL SULFATE 87 87 31 75
BUMETANIDE 87 87 31 71
NAMENDA 85 85 33 35
DIOVAN 82 72 34 47
CEPHALEXIN 79 73 35 94
SPIRIVA 78 66 36 55
BUDESONIDE 72 72 37 168
METHYLPREDNISOLONE 70 57 38 141
HYDRALAZINE HCL 68 68 39 139
FENOFIBRATE 62 38 40 62
FLUTICASONE PROPIONATE 60 50 41 38
ZOLPIDEM TARTRATE 58 54 42 25
DIVALPROEX SODIUM 58 57 42 91
FENTANYL 57 57 S2 44 32
JANUVIA 56 49 45 73
MELOXICAM 55 43 46 41
AZITHROMYCIN 54 48 47 63
METOCLOPRAMIDE HCL 53 50 48 103
CEFUROXIME 51 43 49 158
PAROXETINE HCL 51 51 49 48
LANTUS 50 50 51 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.